Choi, H.G.; Lee, H.K.; Kang, H.S.; Lim, H.; Kim, J.-H.; Kim, J.H.; Kim, N.Y.; Cho, S.-J.; Nam, E.S.; Min, K.-W.;
et al. Possible Association between the Use of Proton Pump Inhibitors and H2 Receptor Antagonists, and Esophageal Cancer: A Nested Case–Control Study Using a Korean National Health Screening Cohort. Pharmaceuticals 2022, 15, 517.
https://doi.org/10.3390/ph15050517
AMA Style
Choi HG, Lee HK, Kang HS, Lim H, Kim J-H, Kim JH, Kim NY, Cho S-J, Nam ES, Min K-W,
et al. Possible Association between the Use of Proton Pump Inhibitors and H2 Receptor Antagonists, and Esophageal Cancer: A Nested Case–Control Study Using a Korean National Health Screening Cohort. Pharmaceuticals. 2022; 15(5):517.
https://doi.org/10.3390/ph15050517
Chicago/Turabian Style
Choi, Hyo Geun, Hong Kyu Lee, Ho Suk Kang, Hyun Lim, Joo-Hee Kim, Ji Hee Kim, Nan Young Kim, Seong-Jin Cho, Eun Sook Nam, Kyueng-Whan Min,
and et al. 2022. "Possible Association between the Use of Proton Pump Inhibitors and H2 Receptor Antagonists, and Esophageal Cancer: A Nested Case–Control Study Using a Korean National Health Screening Cohort" Pharmaceuticals 15, no. 5: 517.
https://doi.org/10.3390/ph15050517
APA Style
Choi, H. G., Lee, H. K., Kang, H. S., Lim, H., Kim, J.-H., Kim, J. H., Kim, N. Y., Cho, S.-J., Nam, E. S., Min, K.-W., & Kwon, M. J.
(2022). Possible Association between the Use of Proton Pump Inhibitors and H2 Receptor Antagonists, and Esophageal Cancer: A Nested Case–Control Study Using a Korean National Health Screening Cohort. Pharmaceuticals, 15(5), 517.
https://doi.org/10.3390/ph15050517